跳至主要内容
临床试验/DRKS00013769
DRKS00013769招募中3 期

Cognitive behavioural therapy for the treatment of late life depression – a multicentre, randomized, observer- blinded, controlled trial (CBTlate) - CBTlate

niversitätsklinikum Köln Klinik für Psychiatrie und Psychotherapie0 个研究点目标入组 248 人开始时间: 2018年6月28日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
248

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
60 Years 至 one(—)
性别
All

入选标准

  • 1. out-patient status
  • 2. male/ female, age = 60 years inclusive at screening
  • 3. depressive episode (moderate to severe according to ICD-10)
  • 4. Geriatric Depression Scale (GDS) > 10
  • 5. Quick Inventory of Depressive Symptomatology (QIDS-C > 10)
  • 6. MMSE > 25 points
  • 7. no or stable (= 6 weeks) antidepressive pharmacological treatment at baseline and stable antidepressive pharmacological treatment during 8-week intervention
  • 8. sufficient German language skills
  • 9. written informed consent signed

排除标准

  • Bipolar depression
  • Schizophrenia
  • Other psychotic disorders
  • Substance abuse or dependency
  • Acute suicidality
  • Anxiety disorder as stand-alone diagnosis (e.g. generalized anxiety disorder, panic disorder, phobia)
  • Obsessive-compulsive disorder as stand-alone diagnosis
  • Participation in another trial of psychotherapeutic/psychiatric intervention parallel to this trial
  • Additional psychological/ psychotherapeutic treatment throughout the study including the follow- up visit
  • Regular use with scheduled dosing of Benzodiazepines (not PRN)
  • Severe or instable medical condition, which clearly impacts on depression or on the ability to participate in the trial
  • Brain disease with severe functional impairement that impacts the ability to participate in the trial (e.g. aphasia, Parkinson’s disease)

研究者

发起方
niversitätsklinikum Köln Klinik für Psychiatrie und Psychotherapie

相似试验